1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Organ Preservation Solution Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Organ Preservation Solution Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Organ Preservation Solution Market Regional Analysis
6.2 North America Organ Preservation Solution Market Revenue 2021-2031 (US$ Thousand)
6.3 North America Organ Preservation Solution Market Forecast Analysis
7. North America Organ Preservation Solution Market Analysis – by Product
7.1 University of Wisconsin Solution
- 7.1.1 Overview
- 7.1.2 University of Wisconsin Solution: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
7.2 Custodiol HTK
- 7.2.1 Overview
- 7.2.2 Custodiol HTK: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
7.3 Perfadex
- 7.3.1 Overview
- 7.3.2 Perfadex: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
7.4 Hypothermosol
- 7.4.1 Overview
- 7.4.2 Hypothermosol: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
8. North America Organ Preservation Solution Market Analysis – by Application
8.1 Static Cold Storage
- 8.1.1 Overview
- 8.1.2 Static Cold Storage: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
8.2 Hypothermic Machine Perfusion
- 8.2.1 Overview
- 8.2.2 Hypothermic Machine Perfusion: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
8.3 Normothermic Machine Perfusion
- 8.3.1 Overview
- 8.3.2 Normothermic Machine Perfusion: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
9. North America Organ Preservation Solution Market Analysis – by Type
9.1 Kidneys
- 9.1.1 Overview
- 9.1.2 Kidneys: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
9.2 Liver
- 9.2.1 Overview
- 9.2.2 Liver: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
9.3 Lungs
- 9.3.1 Overview
- 9.3.2 Lungs: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
9.4 Heart
- 9.4.1 Overview
- 9.4.2 Heart: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
10. North America Organ Preservation Solution Market Analysis – by End User
10.1 Organ Transplant Centers
- 10.1.1 Overview
- 10.1.2 Organ Transplant Centers: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
10.2 Hospitals
- 10.2.1 Overview
- 10.2.2 Hospitals: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
10.3 Specialty Clinics
- 10.3.1 Overview
- 10.3.2 Specialty Clinics: North America Organ Preservation Solution Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
11. North America Organ Preservation Solution Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America Organ Preservation Solution Market Breakdown, by Key
Country, 2025 and 2031 (%)
- 11.2.1.1 North America Organ Preservation Solution Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America Organ Preservation Solution Market – Revenue and Forecast to 2031 (US$ Thousand)
- 11.2.1.1.1 US: North America Organ Preservation Solution Market Breakdown, by Product
- 11.2.1.1.2 US: North America Organ Preservation Solution Market Breakdown, by Application
- 11.2.1.1.3 US: North America Organ Preservation Solution Market Breakdown, by Type
- 11.2.1.1.4 US: North America Organ Preservation Solution Market Breakdown, by End User
- 11.2.1.2 Canada:
North America Organ Preservation Solution Market – Revenue and Forecast to 2031 (US$ Thousand)
- 11.2.1.2.1 Canada: North America Organ Preservation Solution Market Breakdown, by Product
- 11.2.1.2.2 Canada: North America Organ Preservation Solution Market Breakdown, by Application
- 11.2.1.2.3 Canada: North America Organ Preservation Solution Market Breakdown, by Type
- 11.2.1.2.4 Canada: North America Organ Preservation Solution Market Breakdown, by End User
- 11.2.1.3 Mexico:
North America Organ Preservation Solution Market – Revenue and Forecast to 2031 (US$ Thousand)
- 11.2.1.3.1 Mexico: North America Organ Preservation Solution Market Breakdown, by Product
- 11.2.1.3.2 Mexico: North America Organ Preservation Solution Market Breakdown, by Application
- 11.2.1.3.3 Mexico: North America Organ Preservation Solution Market Breakdown, by Type
- 11.2.1.3.4 Mexico: North America Organ Preservation Solution Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Waters Medical Systems LLC
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 XVIVO Perfusion
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 TransMedics
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 OrganOx Limited
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Paragonix Technologies, Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Dr. Franz Koehler Chemie GmbH
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Accord Healthcare
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 21ST Century Medicine
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Bridge to Life Ltd
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations